Lunai Bioworks Inc.
LNAI · XNASCIK 1527728fmd_0EFRC98FW9RP792ZRH1Q2JHTFTManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Jun 30, 2026, 62 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | – | – | 0 |
| Cost of revenue | – | – | – | – | – | – | – | – | – | – |
| Net interest income | – | – | – | – | – | 0 | (0) | – | – | – |
| Gross profit | – | – | – | – | – | – | – | – | – | – |
| Realized investment gains (losses) | – | – | – | – | – | – | – | – | 0 | 0 |
| Research and development | 0 | 1 | 2 | 5 | 16 | 8 | 4 | 3 | 1 | 0 |
| Total operating expenses | 2 | 5 | 11 | 12 | 23 | 116 | 39 | 82 | 189 | 9 |
| Operating income | (2) | (5) | (11) | (12) | (23) | (116) | (39) | (82) | (189) | (9) |
| Interest expense | – | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 |
| Interest and investment income | – | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Other non-operating income (expense) | 0 | (1) | (7) | 1 | (3) | 3 | (1) | (7) | 11 | 5 |
| Income before taxes | (2) | (6) | (18) | (11) | (27) | (113) | (40) | – | – | – |
| Income tax expense | (0) | (0) | – | – | (0) | 0 | – | 0 | 0 | 0 |
| Net income from continuing operations | (2) | (6) | – | – | (27) | (113) | – | – | – | – |
| Net income | (2) | (6) | (18) | (11) | (27) | (113) | (40) | (88) | (178) | (4) |